Winton Capital »

Fulcrum Therapeutics shares owned by Winton Capital

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Winton Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $61k 13k 4.70
2024-09-30 $158k 44k 3.57